Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco Galaxy Bitcoin ETF (BTCO) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

Invesco Galaxy Bitcoin ETFTrade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Invesco Galaxy Bitcoin ETF vs IDEXX Laboratories, Inc. — how do they compare? Invesco Galaxy Bitcoin ETF trades at $62.92, while IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is trading nearer its 52-week high, Invesco Galaxy Bitcoin ETF nearer its low. Which is the better fit depends on your goals.

BTCOIDXX
Sector
Crypto-linkedHealth
52-Week High
$125.14$766.68
52-Week Low
$58.40$526.44
Market Cap
$46.22B
Enterprise Value
$47.12B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco Galaxy Bitcoin ETF

BTCO trades at $63.03, down 0.93% for the session. Technical indicators show a bullish trend with moving averages supporting upward momentum, while oscillators remain neutral. The stock faces resistance at $65 with support at $64. Recent financial data shows key valuation and profitability metrics are currently unavailable for analysis.

The stock's technical setup suggests potential for near-term upside if resistance levels are breached. However, the absence of fundamental financial metrics creates significant uncertainty about the company's underlying business performance and valuation. Investors face elevated risk due to limited visibility into financial health and operational metrics.

IDEXX Laboratories, Inc.

IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.

The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Invesco Galaxy Bitcoin ETF

BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.

Read more on BTCO

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX